TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Fridsbo Pharma AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 80 | 269 | 72 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 3 | 200 | 51 |
EBITDA | 17 | 201 | 51 |
Total assets | 302 | 326 | 107 |
Current assets | 248 | 252 | 107 |
Current liabilities | 72 | 79 | 31 |
Equity capital | 214 | 230 | 74 |
- share capital | 4 | 5 | 5 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 70.9% | 70.6% | 69.2% |
Turnover per employee | 80 | 269 | 72 |
Profit as a percentage of turnover | 3.8% | 74.3% | 70.8% |
Return on assets (ROA) | 1.0% | 61.3% | 47.7% |
Current ratio | 344.4% | 319.0% | 345.2% |
Return on equity (ROE) | 1.4% | 87.0% | 68.9% |
Change turnover | -167 | 198 | 60 |
Change turnover % | -68% | 279% | 471% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.